Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,871 total articles

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

CytomX Therapeutics announced the appointment of Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs to lead global regulatory strategy and support the advancement of its PROBODY® pipeline, including the lead program Varseta-M towards potential approval and commercialization. Dr. Gokhale brings over 25 years of experience in …

Digital Realty Opens First Data Center in Barcelona, Strengthening Its Position Across the Mediterranean

Digital Realty Opens First Data Center in Barcelona, Strengthening Its Position Across the Mediterranean

Digital Realty has opened its first data center in Barcelona, known as BCN1, marking a strategic expansion in the Mediterranean region. Designed to support next-generation technologies such as AI and cloud computing, BCN1 enhances connectivity between key global areas and complements the firm's existing facilities on the Iberian Peninsula. Built wi…

Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

Krystal Biotech, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved VYJUVEK® (beremagene geperpavec-svdt) for treating wounds in dystrophic epidermolysis bullosa (DEB) patients from birth with COL7A1 gene mutations. This marks the first genetic medicine approval in the UK for DEB, complementing prior …

Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option

Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option

Rein Therapeutics, a clinical-stage biotech focused on orphan pulmonary and fibrosis diseases, has closed an underwritten public offering raising $57.5 million. Proceeds will fully fund the ongoing Phase 2 trial of LTI-03 in idiopathic pulmonary fibrosis (IPF), support ongoing clinical and regulatory activities, and extend operational cash runway i…

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Enlivex Ltd. has dosed the first patient in the United States as part of its global Phase 2b clinical trial evaluating Allocetra for treating moderate-to-severe age-related primary knee osteoarthritis. Following FDA IND clearance and Danish regulatory approval, the trial will assess efficacy and safety across multiple countries, targeting an unmet …

Silicon Motion to Attend Upcoming Investor Conferences

Silicon Motion to Attend Upcoming Investor Conferences

Silicon Motion Technology Corporation, a leading supplier of NAND flash controllers worldwide, announced its participation in several prestigious investor conferences throughout May and June 2026, including J.P. Morgan, B. Riley Securities, Morgan Stanley Asia AI Summit, Evercore Global TMT Conference, Citi Taiwan Tech Conference, and Bank of Ameri…

Enhanced (NYSE: ENHA) Selects Rezolve Ai (NASDAQ: RZLV) to Power AI-Native Live Enhanced Consumer Platform and Digital Fan Ecosystem

Enhanced (NYSE: ENHA) Selects Rezolve Ai (NASDAQ: RZLV) to Power AI-Native Live Enhanced Consumer Platform and Digital Fan Ecosystem

Enhanced Group announced a strategic multi-million dollar partnership with Rezolve Ai to utilize AI-powered technologies for its Live Enhanced consumer platform and the inaugural Enhanced Games. The collaboration will start with a mobile-first AI-enabled web experience for event attendees, featuring ticketing, athlete information, and real-time eng…

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Alaunos Therapeutics announced updated preclinical results for ALN1003, their oral metabolic therapeutic candidate, demonstrating positive effects on insulin-resistance-related biomarkers, adipose tissue endocrine markers, and liver histology in diet-induced obesity mouse models. These findings support continued preclinical development for metaboli…

BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ET

BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ET

BIO-key International, Inc., a provider of biometric identity and access management solutions, reported a 34% revenue increase in Q1 2026 to $2.15 million and a substantially improved net loss of $165,000 versus $737,000 in the prior year period. The company expects Q2 revenues to rise 65% with profitability anticipated in the first half of 2026, d…

Anterix and Lynk Global Receive FCC Approval to Test 900 MHz Satellite-Enabled Direct-to-Device Enterprise Communications

Anterix and Lynk Global Receive FCC Approval to Test 900 MHz Satellite-Enabled Direct-to-Device Enterprise Communications

Anterix (NASDAQ: ATEX) and Lynk Global have received experimental license approval from the FCC to test the integration of Lynk's satellite direct-to-device network with Anterix's licensed 900 MHz private wireless broadband spectrum. This collaboration aims to develop private, secure, resilient communication solutions for critical infrastructure se…

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Inspira Technologies secured a $580,000 purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems after a multi-patient clinical evaluation demonstrated the system's operational value. This commercial milestone supports ongoing strategic discussions and promotes Inspira's medical technology busines…

Duos Technologies Reports First Quarter 2026 Results

Duos Technologies Reports First Quarter 2026 Results

Duos Technologies reported a strategic $200 million partnership with Hydra Host to deploy cutting-edge GPU infrastructure, supporting the company's aim to exceed $50 million in revenue for 2026. Despite a Q1 revenue decline versus the prior year due to legacy business ramp-down, Duos strengthened its balance sheet through a $65 million capital rais…

ARMLOGI HOLDING CORP. STRENGTHENS INTERNAL FINANCIAL REPORTING AND MANAGEMENT INFRASTRUCTURE TO SUPPORT OPERATIONAL DISCIPLINE

ARMLOGI HOLDING CORP. STRENGTHENS INTERNAL FINANCIAL REPORTING AND MANAGEMENT INFRASTRUCTURE TO SUPPORT OPERATIONAL DISCIPLINE

Armlogi Holding Corp. announced new internal financial reporting and management infrastructure initiatives including standardized cash flow reporting, higher-frequency monitoring, integrated cross-functional forecasting, and workforce allocation analysis. These measures aim to enhance management visibility, budgeting discipline, and coordination ac…